Lenalidomide, Ibrutinib, and Rituximab in Treating Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma That Is Metastatic or Cannot Be Removed by Surgery
National Cancer Institute (NCI)
National Cancer Institute (NCI)
OHSU Knight Cancer Institute
M.D. Anderson Cancer Center
OHSU Knight Cancer Institute
M.D. Anderson Cancer Center